Matches in Wikidata for { <http://www.wikidata.org/entity/Q56832274> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q56832274 description "article scientifique publié en 2007" @default.
- Q56832274 description "artículu científicu" @default.
- Q56832274 description "im Januar 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56832274 description "wetenschappelijk artikel" @default.
- Q56832274 description "наукова стаття, опублікована в січні 2007" @default.
- Q56832274 name "OC-10 Anticoagulant effects after termination of therapy using once weekly subcutaneous injections of idraparinux in patients with acute venous thromboembolism" @default.
- Q56832274 name "OC-10 Anticoagulant effects after termination of therapy using once weekly subcutaneous injections of idraparinux in patients with acute venous thromboembolism" @default.
- Q56832274 type Item @default.
- Q56832274 label "OC-10 Anticoagulant effects after termination of therapy using once weekly subcutaneous injections of idraparinux in patients with acute venous thromboembolism" @default.
- Q56832274 label "OC-10 Anticoagulant effects after termination of therapy using once weekly subcutaneous injections of idraparinux in patients with acute venous thromboembolism" @default.
- Q56832274 prefLabel "OC-10 Anticoagulant effects after termination of therapy using once weekly subcutaneous injections of idraparinux in patients with acute venous thromboembolism" @default.
- Q56832274 prefLabel "OC-10 Anticoagulant effects after termination of therapy using once weekly subcutaneous injections of idraparinux in patients with acute venous thromboembolism" @default.
- Q56832274 P1433 Q56832274-A9D65F48-EBBB-40B1-82D4-93F72A9094EA @default.
- Q56832274 P1476 Q56832274-02751E87-F709-4F6F-9655-5249569526F2 @default.
- Q56832274 P2093 Q56832274-99E65C80-4F6B-4593-9BD0-297FA3B6B1AD @default.
- Q56832274 P2093 Q56832274-EEF212EF-B169-46E8-AEE5-03409E20B19C @default.
- Q56832274 P2093 Q56832274-F92D0D4B-5CE0-48E2-B6DF-0487FD60F3D2 @default.
- Q56832274 P2093 Q56832274-FA9A4372-BF1E-4A7C-9A91-93128F86B27C @default.
- Q56832274 P304 Q56832274-0EDA3B7B-1E28-4EFA-A79C-1D46A3755709 @default.
- Q56832274 P31 Q56832274-FEA3E507-C374-415E-95A2-75DAE0C4199A @default.
- Q56832274 P356 Q56832274-8FB2CF6E-55EB-4223-9D2A-CA841FAF1838 @default.
- Q56832274 P478 Q56832274-8AC1776B-A7E3-44CD-82DB-188A8FF39120 @default.
- Q56832274 P50 Q56832274-390956F0-A0E1-4934-BE56-EDD7904D4520 @default.
- Q56832274 P577 Q56832274-2DC3AF3B-1DAC-4F1F-8CAF-4A58337B3E58 @default.
- Q56832274 P921 Q56832274-154A047C-9521-4E81-B531-4DDDDE0579B0 @default.
- Q56832274 P921 Q56832274-4172B4EE-A3EB-4CDE-B0B2-D4CBE7EC9AD8 @default.
- Q56832274 P921 Q56832274-74217B8C-9368-410C-8700-A0A4DF15E9D9 @default.
- Q56832274 P356 S0049-3848(07)70153-6 @default.
- Q56832274 P1433 Q15758741 @default.
- Q56832274 P1476 "OC-10 Anticoagulant effects after termination of therapy using once weekly subcutaneous injections of idraparinux in patients with acute venous thromboembolism" @default.
- Q56832274 P2093 "C.H. Weiss" @default.
- Q56832274 P2093 "I. Joerg" @default.
- Q56832274 P2093 "J. Harenberg" @default.
- Q56832274 P2093 "T. Fenyvesi" @default.
- Q56832274 P304 "S144" @default.
- Q56832274 P31 Q13442814 @default.
- Q56832274 P356 "10.1016/S0049-3848(07)70153-6" @default.
- Q56832274 P478 "120" @default.
- Q56832274 P50 Q37382592 @default.
- Q56832274 P577 "2007-01-01T00:00:00Z" @default.
- Q56832274 P921 Q215118 @default.
- Q56832274 P921 Q63279445 @default.
- Q56832274 P921 Q9397786 @default.